Oncology in the NHS – could this be pharma’s moment?
PharmaTimes Magazine
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
Through the barricades
Dismantling health stigma – examining the role for pharma
March 2026
PharmaTimes March edition ponders, wrestles and wonders at the present life sciences zeitgeist – what a time to be alive! As the cover boldly suggests, we are in an era of patient autonomy and, thus, a brave new landscape in which the population expect and deserve access to medicines. Features examine shifting politics, the rise of “super employees,” and ongoing innovation. Articles cover GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI’s relentless advance.
Sharp focus
Digital healthcare – shaping a new type of patient experience
Formation changes
Who, where and when? Redrawing your NHS stakeholder map for 2026
Predicting the present
What’s topping pharma’s strategic agenda for 2026?
Boom or bust
The GLP-1 inflection point is a moment of reckoning for us all
Speaking volumes
Supporting spokespeople – a guide for health sector communicators
